STOCK TITAN

TD SYNNEX (SNX) SEC Filings, Oct 7-9, 2025

SNX NYSE
Rhea-AI Summary

TD SYNNEX director and officer Dennis Polk reported a non-derivative sale of 870 shares of common stock on 10/07/2025 at a price of $158.65 per share. After the sale he directly beneficially owns 31,117 shares and indirectly owns 81,660 shares through a trust, showing continued significant aggregate holdings while executing a small disposition. The form was signed by an attorney-in-fact on 10/09/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX Corp (SNX) Form 144 reports a proposed sale of 17,500 common shares through Morgan Stanley Smith Barney LLC on 10/09/2025, with an aggregate market value of $2,738,730.75. The filer states these shares were acquired the same day via a stock option exercise and paid for in cash. The filing lists 81,437,855 shares outstanding, and shows recent disposals by the Polk Family Trust of 3,000 shares on each of 08/04/2025, 09/04/2025, and 10/06/2025 generating gross proceeds of $426,529.20, $445,486.80, and $477,258.30 respectively. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

TD SYNNEX Corporation filed an 8-K reporting an Underwriting Agreement relating to the Notes dated October 7, 2025. The agreement names several underwriters with BofA Securities, Inc., HSBC Securities (USA) Inc., Scotia Capital (USA) Inc. and Wells Fargo Securities, LLC acting as representatives. The filing is presented with an Inline XBRL cover page and is dated October 8, 2025. The document is signed by David Jordan, Executive Vice President and Chief Financial Officer. No further terms of the Notes (such as principal amount, interest rate, maturity, or expected use of proceeds) are included in the disclosed text.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.45%
Tags
current report
Rhea-AI Summary

Thompson Reyna, President, North America and an officer of TD SYNNEX Corp. (SNX), reported sales of company common stock on 10/03/2025 and 10/06/2025

The filing shows three non-derivative sales totaling 560 shares, reducing direct beneficial ownership to 12,583 shares after transactions. Reported prices ranged from $157.84 to $158.66.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Dennis Polk, a director and officer of TD SYNNEX Corp. (SNX), reported multiple sales of common stock executed on 10/06/2025 under a Rule 10b5-1 trading plan. The filing lists discrete disposals of 24, 1,276, 1,500, and 200 shares at weighted average prices between $157.92 and $160.96, with corresponding beneficial ownership balances reported as 84,636, 83,360, 81,860, and 81,660 shares (held indirectly by a trust). The form also records a larger disposal line showing 31,987 shares sold. The reporting person states the sales were effectuated pursuant to a 10b5-1 plan adopted on 10/13/2024 on behalf of the Polk family trust, where he serves as trustee. The form is signed by an attorney-in-fact on 10/07/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Henry John Paul, the Chief Accounting Officer of TD SYNNEX Corp. (SNX), reported two open-market sales of company common stock. On 10/03/2025 he sold 173 shares at $158.66, reducing his holdings to 20,250 shares. On 10/06/2025 he sold 95 shares at $157.84, leaving 20,155 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 10/07/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Insider sales by TD SYNNEX Chief Legal Officer: The filing shows that David R. Vetter, Chief Legal Officer and officer of TD SYNNEX (SNX), reported two open-market dispositions of common stock in early October. On 10/03/2025 he sold 734 shares at $158.66, and on 10/06/2025 he sold 405 shares at $157.84, reducing his holdings from 65,119 to 64,714 shares. The Form 4 was signed by an attorney-in-fact on 10/07/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The reporting person, Dennis Polk, disclosed three open-market sales of TD SYNNEX Corp. (SNX) common stock in early October 2025. On 10/03/2025 he sold 1,210 shares at $158.66, leaving 34,085 shares held directly. On 10/06/2025 he sold 1,336 and 762 shares at $157.84, after which direct holdings were 32,749 and then 31,987 shares. He also reports 84,660 shares held indirectly by trust. No derivative transactions were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX (SNX) Chief Executive Officer and Director Patrick Zammit reported two open-market sales totaling 1,712 shares: 1,103 shares sold on 10/03/2025 at $158.66 per share and 609 shares sold on 10/06/2025 at $157.84 per share. After these transactions his direct beneficial ownership is reported as 163,383 shares. The Form 4 was signed by an attorney-in-fact on 10/07/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Jordan David Gregory, identified as Chief Financial Officer, reported two open-market sales of TD SYNNEX Corp (SNX) common stock. On 10/03/2025 he sold 431 shares at $158.66, leaving 12,824 shares owned. On 10/06/2025 he sold an additional 238 shares at $157.84, leaving 12,586 shares beneficially owned. Both holdings are reported as direct ownership. The Form 4 was signed via attorney-in-fact Cheryl Grant on 10/07/2025. The report indicates compliance with Section 16 reporting requirements and discloses only routine disposition activity; no derivative transactions or additional notes were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many TD SYNNEX (SNX) SEC filings are available on StockTitan?

StockTitan tracks 185 SEC filings for TD SYNNEX (SNX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for TD SYNNEX (SNX)?

The most recent SEC filing for TD SYNNEX (SNX) was filed on October 9, 2025.